These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 8745736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
    Silvie O, Rubinstein E, Franetich JF, Prenant M, Belnoue E, Rénia L, Hannoun L, Eling W, Levy S, Boucheix C, Mazier D.
    Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M, Jossang A, Franetich JF, Siau A, Ciceron L, Hannoun L, Sauerwein R, Frappier F, Rasoanaivo P, Snounou G, Mazier D.
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro survival and retention of infectivity of Plasmodium yoelii sporozoites over extended periods of time.
    Siu NF, Sedegah M, Hoffman SL.
    J Parasitol; 1994 Oct; 80(5):826-9. PubMed ID: 7931920
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression.
    Sacci JB, Ribeiro JM, Huang F, Alam U, Russell JA, Blair PL, Witney A, Carucci DJ, Azad AF, Aguiar JC.
    Mol Biochem Parasitol; 2005 Aug; 142(2):177-83. PubMed ID: 15876462
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver.
    Baer K, Roosevelt M, Clarkson AB, van Rooijen N, Schnieder T, Frevert U.
    Cell Microbiol; 2007 Feb; 9(2):397-412. PubMed ID: 16953803
    [Abstract] [Full Text] [Related]

  • 12. Primary infection of C57BL/6 mice with Plasmodium yoelii induces a heterogeneous response of NKT cells.
    Soulard V, Roland J, Sellier C, Gruner AC, Leite-de-Moraes M, Franetich JF, Rénia L, Cazenave PA, Pied S.
    Infect Immun; 2007 May; 75(5):2511-22. PubMed ID: 17307938
    [Abstract] [Full Text] [Related]

  • 13. [Inhibition of CpG oligodeoxynucleotide on the development of pre-erythrocytic stage of Plasmodium].
    Chen JD, Zhou TL, Xu WY, Ding Y, Huang FS.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Feb 28; 27(1):1-5. PubMed ID: 19459490
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection.
    Hafalla JC, Rai U, Bernal-Rubio D, Rodriguez A, Zavala F.
    J Infect Dis; 2007 Dec 15; 196(12):1827-35. PubMed ID: 18190264
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R, Charoenvit Y, Corradin G, De La Vega P, Franke ED, Hoffman SL.
    J Immunol; 1996 Nov 01; 157(9):4061-7. PubMed ID: 8892640
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.